Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Tothill

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Scientific Reports|June 25, 2020
Enhancing the anti-tumour activity of <sup>177</sup>Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARPCarleen Cullinane, Kelly Waldeck, Laura Kirby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown PrimaryTharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneityChian A Chang, David A Pattison, Richard W Tothill, et al.
Scientific Reports|December 17, 2013
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumoursStephen Q Wong, Jason Li, Renato Salemi, et al.
Theranostics|September 29, 2023
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to <sup>177</sup>Lutetium-DOTA-octreotate radionuclide therapyKelly Waldeck, Jessica Van Zuylekom, Carleen Cullinane, et al.
Pathology|December 9, 2014
Development and validation of a gene expression tumour classifier for cancer of unknown primaryRichard W Tothill, Fan Shi, Lisa Paiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal responseRita A Busuttil, Joshy George, Richard W Tothill, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
International Journal of Cancer|February 26, 2016
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse modelKelly Waldeck, Carleen Cullinane, Kerry Ardley, et al.
Plos One|April 27, 2012
MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancersGeorgina L Ryland, Jennifer L Bearfoot, Maria A Doyle, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Scientific Reports|June 25, 2020
Enhancing the anti-tumour activity of <sup>177</sup>Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARPCarleen Cullinane, Kelly Waldeck, Laura Kirby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
Evaluating the Utility of <sup>18</sup>F-FDG PET/CT in Cancer of Unknown PrimaryTharani Sivakumaran, Anthony Cardin, Jason Callahan, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneityChian A Chang, David A Pattison, Richard W Tothill, et al.
Scientific Reports|December 17, 2013
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumoursStephen Q Wong, Jason Li, Renato Salemi, et al.
Theranostics|September 29, 2023
A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to <sup>177</sup>Lutetium-DOTA-octreotate radionuclide therapyKelly Waldeck, Jessica Van Zuylekom, Carleen Cullinane, et al.
Pathology|December 9, 2014
Development and validation of a gene expression tumour classifier for cancer of unknown primaryRichard W Tothill, Fan Shi, Lisa Paiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal responseRita A Busuttil, Joshy George, Richard W Tothill, et al.
Bioinformatics (Oxford, England)|January 7, 2014
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped readsJan Schröder, Arthur Hsu, Samantha E Boyle, et al.
International Journal of Cancer|February 26, 2016
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse modelKelly Waldeck, Carleen Cullinane, Kerry Ardley, et al.
Plos One|April 27, 2012
MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancersGeorgina L Ryland, Jennifer L Bearfoot, Maria A Doyle, et al.
Pageof 7